Todd Rethemeier, brings more than two decades of financial experience to ABM, focusing on innovative technologies and disruptive business models.
Rethemeier started his career in management consulting at Booz-Allen & Hamilton, where he traveled the world advising telecommunications and media companies on business and marketing strategy, capital budgeting, and financial impacts of changing regulations. He then spent several years as an equity research analyst covering technology and telecommunications companies at major Wall Street firms, including Bank of America, JP Morgan, and Bear Stearns. After years of following other innovative companies as they disrupted industries, Rethemeier started his own equity research company and spent much of the next decade on the forefront of the independent research movement on Wall Street. Most recently, he had been providing consulting and CFO services to startup businesses in the technology industry before joining Aesthetics Biomedical.
Rethemeier has been recognized by many publications as a leading Wall Street analyst, being named to the Wall Street Journal’s “Best on the Street” ranking three times, as well as similar awards from the Financial Times, Forbes, and Institutional Investor. He holds a Bachelor of Science and Masters degree in Operations Research & Industrial Engineering, and an MBA, all from Cornell University.